Granisetron Fresenius Kabi 1 mg/ml inj./inf. sol. (conc.) i.v. amp. België - Engels - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

granisetron fresenius kabi 1 mg/ml inj./inf. sol. (conc.) i.v. amp.

fresenius kabi sa-nv - granisetron hydrochloride 1,12 mg/ml - eq. granisetron 1 mg/ml - concentrate for solution for injection/infusion - 1 mg/ml - granisetron hydrochloride 1.12 mg/ml - granisetron

Granisetron Fresenius Kabi 1 mg/ml inj./inf. sol. (conc.) i.v. amp. België - Engels - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

granisetron fresenius kabi 1 mg/ml inj./inf. sol. (conc.) i.v. amp.

fresenius kabi sa-nv - granisetron hydrochloride 1,12 mg/ml - eq. granisetron 1 mg/ml - concentrate for solution for injection/infusion - 1 mg/ml - granisetron hydrochloride 1.12 mg/ml - granisetron

GRANISETRON HYDROCHLORIDE tablet, film coated Verenigde Staten - Engels - NLM (National Library of Medicine)

granisetron hydrochloride tablet, film coated

natco pharma limited - granisetron hydrochloride (unii: 318f6l70j8) (granisetron - unii:wzg3j2mcol) - granisetron hydrochloride tablets usp are indicated for the prevention of: nausea and vomiting associated with initial and repeat courses of emetogenic cancer therapy, including high-dose cisplatin. nausea and vomiting associated with radiation, including total body irradiation and fractionated abdominal radiation. granisetron hydrochloride is contraindicated in patients with known hypersensitivity to the drug or any of its components.

NAT-GRANISETRON TABLET Canada - Engels - Health Canada

nat-granisetron tablet

natco pharma (canada) inc - granisetron (granisetron hydrochloride) - tablet - 1mg - granisetron (granisetron hydrochloride) 1mg - 5-ht3 receptor antagonists

Granisetron 3 mg/3mL Nieuw-Zeeland - Engels - Medsafe (Medicines Safety Authority)

granisetron 3 mg/3ml

devatis limited - granisetron hydrochloride 1.12 mg/ml equivalent to granisetron 1 mg - solution for injection - 1 mg/ml - active: granisetron hydrochloride 1.12 mg/ml equivalent to granisetron 1 mg excipient: citric acid monohydrate hydrochloric acid sodium chloride sodium hydroxide water for injection - for the prevention and treatment of nausea and vomiting induced by cytotoxic chemotherapy in adults for the prevention of nausea and vomiting induced by cytotoxic chemotherapy in children

GRANISETRON HYDROCHLORIDE INJECTION LIQUID Canada - Engels - Health Canada

granisetron hydrochloride injection liquid

omega laboratories limited - granisetron (granisetron hydrochloride) - liquid - 1mg - granisetron (granisetron hydrochloride) 1mg - 5-ht3 receptor antagonists

GRANISETRON HYDROCHLORIDE INJECTION SOLUTION Canada - Engels - Health Canada

granisetron hydrochloride injection solution

strides pharma canada inc - granisetron (granisetron hydrochloride) - solution - 1mg - granisetron (granisetron hydrochloride) 1mg - 5-ht3 receptor antagonists

Granisetron-AFT Nieuw-Zeeland - Engels - Medsafe (Medicines Safety Authority)

granisetron-aft

aft pharmaceuticals ltd - granisetron hydrochloride 1.12 mg/ml equivalent to granisetron 1 mg/ml; granisetron hydrochloride 1.12 mg/ml equivalent to granisetron 1 mg/ml - concentrate for injection - 1 mg/ml - active: granisetron hydrochloride 1.12 mg/ml equivalent to granisetron 1 mg/ml excipient: hydrochloric acid nitrogen sodium chloride sodium hydroxide water for injection active: granisetron hydrochloride 1.12 mg/ml equivalent to granisetron 1 mg/ml excipient: citric acid monohydrate nitrogen sodium chloride sodium citrate water for injection - for the prevention & treatment of nausea & vomiting induced by cytotoxic chemotherapy (adults & children)